In 2019, Tumor Treating Fields became the second therapy approved by the U.S. Food and Drug Administration for treatment of malignant pleural mesothelioma.
Funding for cancer research, including mesothelioma research, has significantly dropped as a result of financial strain caused by the COVID-19 pandemic. The mesothelioma…
September is National Ovarian Cancer Awareness Month. The disease is receiving more attention this year following multimillion-dollar verdicts awarded in talc lawsuits that sparked…
